MRC1 and endometrial carcinoma: We found that the distribution of molecular subgroups in endometrial carcinomas was consistent with previous reports (Table 4) [21–27], with the majority falling into the NSMP subgroup (39–64%), followed by the MMR-d (17–39%), the p53-abn (8–21%), and the POLE-mut (4-13.6%).